Filing Details
- Accession Number:
- 0001127602-25-019182
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-15 15:59:27
- Reporting Period:
- 2025-07-14
- Filing Date:
- 2025-07-15
- Accepted Time:
- 2025-07-15 15:59:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc. | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1771814 | Jeffrey Bluestone | 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Transaction Summary
| Sold: | 5,000 shares | Avg. Price: $109.74 | Total Value: $548,700.00 |
| Number of Shares After Transactions: | 8,920 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-07-14 | 5,000 | $67.45 | 13,920 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-07-14 | 5,000 | $109.74 | 8,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2025-07-14 | 5,000 | $0.00 | 5,000 | $67.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,665 | 2031-05-12 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.
Billionaire Hedge Funds
